Company Announcements

Grant of Long Term Incentive Plan Awards

Source: RNS
RNS Number : 2687L
Craneware plc
04 September 2019
 

 

Craneware plc

("Craneware" or the "Company")

 

Grant of Long Term Incentive Plan Awards

 

4 September 2019 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that on 4 September 2019, under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), a conditional award of ordinary shares of 1p each in the Company ("Shares") was granted to two Directors of the Company as follows:  

 

Director

No. of Shares over which a conditional share award was granted

Percentage of issued share capital

Keith Neilson (CEO)

17,100

0.06%

Craig Preston (CFO)

12,710

0.05%

 

The awards will ordinarily vest after three years subject to:

 

(i) the satisfaction of certain performance conditions based on the Company's total shareholder return ("TSR") performance relative to the performance achieved by the constituent companies within the FTSE AIM 100 Index; and

(ii) the Director's continued employment.

 

The performance conditions are measured in three tranches such that one third of the Shares over which the LTIP awards subsist will vest based on performance over the three years ending on 30 June 2020, one third based on performance over the three years ending 30 June 2021 and the final third based on performance over the three years to 30 June 2022 - an aggregate five year period. Any tranche (or part thereof) that does not meet the performance criteria will lapse and not be re-tested in later years.

 

There was no consideration for the grant of the LTIP awards and no consideration will be payable by the award holders to receive the Shares from these LTIP awards, if and to the extent that they vest. 

 

 

PDMR notification: Keith Neilson

 

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Keith Neilson

 

2.   Reason for the notification

a) Position / status                                               CEO

b) Initial notification / Amendment                       Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument                                                         Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code                                         ISIN GB00B2425G68

 

c) Nature of the transaction                                Grant of conditional share award under the Craneware plc

                                                                            Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s)                                   Volume(s) granted 17,100, Price(s) £0

 

e) Aggregated information:

                                    i. Aggregated volume      Aggregate volume granted 17,100

                                    ii. Price                            Price(s) £0

 

f) Date of the transaction                                  2019-09-04

 

g) Place of the transaction                                 Outside a trading venue

 

PDMR notification: Craig Preston

 

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Craig Preston

 

2.   Reason for the notification

a) Position / status                                              CFO

b) Initial notification / Amendment                       Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument                                                         Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code                                         ISIN GB00B2425G68

 

c) Nature of the transaction                                Grant of conditional share award under the Craneware plc

                                                                            Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s)                                   Volume(s) granted 12,710, Price(s) £0

 

e) Aggregated information:

                                    i. Aggregated volume        Aggregate volume granted 12,710

                                    ii. Price                               Price(s) £0

 

f) Date of the transaction                                  2019-09-04

 

g) Place of the transaction                                Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt (NOMAD & Joint Broker)               

Investec Bank (Joint Broker)

Alma (Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)203 405 0205

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Guy Pengelley

Sebastian Lawrence

Henry Reast

Hilary Buchanan

Helena Bogle

 

 

 

 

 

 

 

 

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSFFWLFUSEFU